Announced Fri, 17 Jul · 09:36 IST
47th AGM outcome: all 4 resolutions passed, interim dividend confirmed
Board & Shareholder Meetings View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹3451.50
prior close
₹3384.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.6-0.6-0.7+0.4+3.6+0.0-0.6-2.3—————
Up moveDown movePending
AI summary
Ajanta Pharma held its 47th AGM on 16 July 2026 via video conferencing. All 4 resolutions passed: adoption of audited financial statements (99.99% in favour), confirmation of interim dividend for FY ended March 2025 (99.99%), reappointment of Mr. Mannalal Agrawal as Director (98.71%), and ratification of Cost Auditor remuneration for FY 2025-2027 (99.99%). Over 89% of shares were polled.
Likely market impact
Strong shareholder support across all resolutions; AGM business concluded smoothly. No material negative signal.